Patent applications and USPTO patent grants for RXi Pharmaceuticals Corporation.The latest application filed is for "reduced size self-delivering rnai compounds".
Patent | Date |
---|---|
Reduced Size Self-delivering Rnai Compounds App 20190161757 - Khvorova; Anastasia ;   et al. | 2019-05-30 |
Reduced Size Self-delivering Nucleic Acid Compounds Targeting Long Non-coding Rna App 20190048341 - Cardia; James ;   et al. | 2019-02-14 |
Methods For Treating Skin Disorders And Conditions Utilizing Haptens App 20190029974 - Cauwenbergh; Gerard ;   et al. | 2019-01-31 |
RNA interference in ocular indications Grant 10,184,124 - Libertine , et al. Ja | 2019-01-22 |
Inhibition of PCSK9 through RNAI Grant 10,167,471 - Kamens , et al. J | 2019-01-01 |
Rna Interference In Dermal And Fibrotic Indications App 20180371464 - Khvorova; Anastasia ;   et al. | 2018-12-27 |
Neutral nanotransporters Grant 10,138,485 - Khvorova , et al. Nov | 2018-11-27 |
Modified RNAi polynucleotides and uses thereof Grant 10,131,904 - Pavco , et al. November 20, 2 | 2018-11-20 |
Rna Interference In Skin Indications App 20180327748 - Khvorova; Anastasia ;   et al. | 2018-11-15 |
Methods For The Treatment Of Alopecia Areata Utilizing Gene Modulation Approaches App 20180263925 - Cauwenbergh; Gerard ;   et al. | 2018-09-20 |
Reduced size self-delivering RNAi compounds Grant 10,041,073 - Khvorova , et al. August 7, 2 | 2018-08-07 |
Nucleic Acid Molecules Targeting Superoxide Dismutase 1 (sod1) App 20180195072 - Cardia; James ;   et al. | 2018-07-12 |
Methods For Treating Neurological Disorders Using A Synergistic Small Molecule And Nucleic Acids Therapeutic Approach App 20180195066 - Byrne; Michael ;   et al. | 2018-07-12 |
Rna Duplexes With Single Stranded Phosphorothioate Nucleotide Regions For Additional Functionality App 20180155718 - Woolf; Tod M. ;   et al. | 2018-06-07 |
RNA interference in dermal and fibrotic indications Grant 9,963,702 - Khvorova , et al. May 8, 2 | 2018-05-08 |
RNA interference in skin indications Grant 9,938,530 - Khvorova , et al. April 10, 2 | 2018-04-10 |
Methods For Treating Aging And Skin Disorders Using Nucleic Acids Targeting Tyr Or Mmp1 App 20180030451 - Cauwenbergh; Gerard | 2018-02-01 |
RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality Grant 9,745,574 - Woolf , et al. August 29, 2 | 2017-08-29 |
Inhibition Of Pcsk9 Through Rnai App 20170137823 - Kamens; Joanne ;   et al. | 2017-05-18 |
Rna Interference In Dermal And Fibrotic Indications App 20170067056 - Khvorova; Anastasia ;   et al. | 2017-03-09 |
Methods For Treating Cancer Using Nucleic Acids Targeting Mdm2 Or Mycn App 20170051288 - Byrne; Michael ;   et al. | 2017-02-23 |
Methods For Treatment Of Disorders In The Front Of The Eye Utilizing Nucleic Acid Molecules App 20170051290 - Byrne; Michael ;   et al. | 2017-02-23 |
Rna Interference In Skin Indications App 20170009239 - Khvorova; Anastasia ;   et al. | 2017-01-12 |
Inhibition of PCSK9 through RNAi Grant 9,493,774 - Kamens , et al. November 15, 2 | 2016-11-15 |
Methods For Treatment Of Wound Healing Utilizing Chemically Modified Oligonucleotides App 20160304875 - Cauwenbergh; Gerard ;   et al. | 2016-10-20 |
Reduced Size Self-delivering Rnai Compounds App 20160244765 - Khvorova; Anastasia ;   et al. | 2016-08-25 |
RNA interference in dermal and fibrotic indications Grant 9,340,786 - Khvorova , et al. May 17, 2 | 2016-05-17 |
Reduced Size Self-delivering Rnai Compounds App 20160130578 - Khvorova; Anastasia ;   et al. | 2016-05-12 |
Inhibition Of Map4k4 Through Rnai App 20160115484 - Woolf; Tod M. ;   et al. | 2016-04-28 |
Rna Interference In Ocular Indications App 20160115482 - Libertine; Lyn ;   et al. | 2016-04-28 |
RNA interference in skin indications Grant 9,303,259 - Khvorova , et al. April 5, 2 | 2016-04-05 |
Reduced size self-delivering RNAi compounds Grant 9,175,289 - Khvorova , et al. November 3, 2 | 2015-11-03 |
RNA interference in ocular indications Grant 9,095,504 - Libertine , et al. August 4, 2 | 2015-08-04 |
Inhibition of MAP4K4 through RNAI Grant 9,074,211 - Woolf , et al. July 7, 2 | 2015-07-07 |
Means And Methods For The Specific Modulation Of Target Genes In The Cns And The Eye And Methods For Their Identification App 20150105448 - DRUMM; Karina ;   et al. | 2015-04-16 |
Reduced Size Self-delivering Rnai Compounds App 20140364482 - Khvorova; Anastasia ;   et al. | 2014-12-11 |
Rna Interference In Skin Indications App 20140315974 - KHVOROVA; ANASTASIA ;   et al. | 2014-10-23 |
Phagocytic cell delivery of RNAI Grant 8,815,818 - Samarsky , et al. August 26, 2 | 2014-08-26 |
Reduced size self-delivering RNAi compounds Grant 8,796,443 - Khvorova , et al. August 5, 2 | 2014-08-05 |
Interference In Dermal And Fibrotic Indications App 20140113950 - Khvorova; Anastasia ;   et al. | 2014-04-24 |
RNA interference in skin indications Grant 8,664,189 - Khvorova , et al. March 4, 2 | 2014-03-04 |
Inhibition Of Pcsk9 Through Rnai App 20130197055 - Kamens; Joanne ;   et al. | 2013-08-01 |
Rna Duplexes With Single Stranded Phosphorothioate Nucleotide Regions For Additional Functionality App 20120065243 - Woolf; Tod M. ;   et al. | 2012-03-15 |
Inhibition Of Map4k4 Through Rnai App 20120059046 - Woolf; Tod M ;   et al. | 2012-03-08 |
Reduced Size Self-delivering Rnai Compounds App 20120040459 - Khvorova; Anastasia ;   et al. | 2012-02-16 |
Phagocytic Cell Delivery Of Rnai App 20120016005 - Samarsky; Dmitry ;   et al. | 2012-01-19 |
Reduced Size Self-delivering Rnai Compounds App 20110263680 - Khvorova; Anastasia ;   et al. | 2011-10-27 |
Rnai Constructs And Uses Thereof App 20110251258 - Samarsky; Dmitry ;   et al. | 2011-10-13 |
Rna Interference In Skin Indications App 20110237648 - Khvorova; Anastasia ;   et al. | 2011-09-29 |
Modified Rnai Polynucleotides And Uses Thereof App 20110039914 - Pavco; Pamela A. ;   et al. | 2011-02-17 |
Novel Compositions Of Chemically Modified Small Interfering Rna App 20100069620 - Zon; Gerald | 2010-03-18 |
Tripartite RNAi constructs App 20090131360 - Woolf; Tod M. ;   et al. | 2009-05-21 |
NCAGE Code | 6PD93 | RXI PHARMACEUTICALS CORPORATION |
NCAGE Code | 5D6H9 | RXI PHARMACEUTICALS CORPORATION!DBA (A DEVELOPMENT STAGE COMPANY) |
CAGE Code | 6PD93 | RXI PHARMACEUTICALS CORPORATION |
CAGE Code | 5D6H9 | RXI PHARMACEUTICALS CORPORATION (A DEVELOPMENT STAGE COMPANY) |
DUNS | 078313898 | RXI PHARMACEUTICALS CORPORATION |
DUNS | 932221729 | RXI PHARMACEUTICALS CORPORATION |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.